Lansoprazole/Amoxicillin/Metronidazole

兰索拉唑/阿莫西林/甲硝唑

Report date: 2022/03/15 13:44:21

Base Information

Drug NameLansoprazole/Amoxicillin/Metronidazole
Drug Alias Name阿莫西林/兰索拉唑/甲硝唑Amoxicillin/Lansoprazole/MetronidazoleLansoprazole/Amoxicillin hydrate/MetronidazoleLampion
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionProton pump inhibitorsBacterial penicillin-binding protein inhibitors
TargetsProton pumpBacterial penicillin-binding protein
Therapy Area/IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[6] 
Global Approved IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2010/07/15
Country/TerritoryJapan
CombinationsYes AmoxicillinMetronidazoleLansoprazole
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BD03
Related LinksKEGG